← Back to all stories
New Hepatitis B Drug Shows Promise With Functional Cure in Clinical Trial
Photo: Towfiqu barbhuiya / Unsplash
A new drug called bepirovirsen has demonstrated the ability to achieve a functional cure in approximately one in five patients with chronic hepatitis B, according to research published in the New England Journal of Medicine. This represents meaningful progress beyond current standard treatments in offering hope to millions living with the virus.
A new drug called bepirovirsen has demonstrated the ability to achieve a functional cure in approximately one in five patients with chronic hepatitis B, according to research published in the New England Journal of Medicine. This represents meaningful progress beyond current standard treatments in offering hope to millions living with the virus.